Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-04

Clinical Trial Update: Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how genetic factors and brain mechanisms relate to naltrexone's effectiveness in treating alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2018-06-04